Product Images Venlafaxine Hydrochloride
View Photos of Packaging, Labels & Appearance
- Label - 70934 349 30 Rev A 05 19
 - Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 01
 - Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 02
 - Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 03
 - Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 04
 
Product Label Images
The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 70934-349 by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 70934 349 30 Rev A 05 19
                            
                                This is a prescription drug for Venlafaxine Hydrochloride Extended-Release capsules of 75mg with a pack size of 30. The National Drug Code is 70934349-30. The text lacks useful information and structure, suggesting that the process did not occur successfully.*
Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 01
                            
                                This is a list of drugs and their interactions with each other and a specific enzyme called CYP2D6. It also includes information about the analyte venlafaxine and PK fold changes. The recommendations for use with these drugs vary and include avoiding concomitant use, using with caution in certain populations, and monitoring blood pressure. There is no further context or explanation provided.*
Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 02
                            
                                This is a list of drugs and their potential interactions and effects when used concomitantly. The drugs include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, and lithium. The text provides information regarding the Analyte PKFold Change and 90% CRecommendation for each drug, as well as the potential effects on Cmax and Auc. There is a note that suggests caution and monitoring of blood pressure when using certain drugs together. Overall, this text provides insight into potential drug interactions and the need for careful consideration when using multiple medications concurrently.*
Venlafaxine hydrochloride extended-release capsules, USP - 719c77d6 c5bc 4d70 89b1 e84f1bf4b9dd 04
                            
                                The text is a combination of letters and numbers ("eHCI" and "H4C0 C") followed by the name of a substance ("venlafaxine hydrochloride"). Therefore, it seems like the text is referring to a chemical compound or medication. Specifically, "venlafaxine hydrochloride" is a prescription drug used to treat depression, anxiety, and panic disorder. However, the first two parts of the text ("eHCI" and "H4C0 C") do not provide any additional information and may be errors from .*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.